XML 28 R15.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2025

9. Goodwill and Intangible Assets

As of March 31, 2025 and December 31, 2024, the Company’s goodwill balance was $150,760 and $162,333, respectively. The change in the period was due to changes within the measurement period, as described in Footnote 4, Acquisition. The Company’s goodwill resulted from the acquisition of BDSI on March 22, 2022 and the Ironshore Acquisition on September 3, 2024.

The following table sets forth the cost, accumulated amortization, and carrying amount of intangible assets as of March 31, 2025 and December 31, 2024:


	March 31, 2025						December 31, 2024
		Cost		Accumulated Amortization		Carrying Amount		Cost		Accumulated Amortization		Carrying Amount
Jornay	$	635,000	$	(48,199)	$	586,801	$	635,000	$	(27,242)	$	607,758
Belbuca		360,000		(228,063)		131,937		360,000		(209,214)		150,786
Nucynta Products		521,170		(451,940)		69,230		521,170		(438,094)		83,076
Symproic		70,000		(22,038)		47,962		70,000		(20,218)		49,782
Total intangible assets	$	1,586,170	$	(750,240)	$	835,930	$	1,586,170	$	(694,768)	$	891,402

The following table presents amortization expense recognized in cost of product revenues for the three months ended March 31, 2025 and 2024:


	Three Months Ended March 31,
		2025		2024
Jornay PM	$	20,957	$	—
Belbuca		18,849		18,848
Nucynta Products		13,846		13,845
Symproic		1,821		1,824
Total amortization expense	$	55,473	$	34,517

As of March 31, 2025, the remaining amortization expense expected to be recognized is as follows:


Years ended December 31,	Jornay		Belbuca		Nucynta Products		Symproic		Total
2025	$	62,872	$	56,544	$	41,538	$	5,465	$	166,419
2026		83,829		75,393		27,692		7,285		194,199
2027		83,829		—		—		7,285		91,114
2028		83,829		—		—		7,285		91,114
2029		83,829		—		—		7,285		91,114
Thereafter		188,613		—		—		13,357		201,970
Remaining amortization expense	$	586,801	$	131,937	$	69,230	$	47,962	$	835,930